Skip to content
Navigate to homepage - Cerba Research


Learn how Cerba Research’s team can assist you in outsourcing your immuno-assay research inquiries. Get in touch today to find out more.

You can rely on Cerba Research to outsource your research questions, including efficacy, safety, passive immunization, immunogenicity, pharmaco kinetics, pathogenicity, antiviral therapy, antiviral prophylaxis, drug delivery, resistance mutants, and more.

With more than 4500m2 clinical laboratories, equipped with the latest technologies, we have the in-house capabilities to perform several read outs. We are experts on evaluation of immune responses, antibody detection, vaccine efficacy; immunogenicity, pharmaco kinetics, immunopathology, antiviral therapy, antiviral prophylaxis and more. Our portfolio of immunological assays include: Haemagglutination inhibition, Neutralizing antibodies, Neuraminidase inhibition, cell mediated immunity and immunogenicity testing.

Our Immunoassays

We offer a wide range of immunoassay services tailored to meet your specific research needs. Our team of experienced scientists and technicians employ cutting-edge technologies and industry best practices to deliver accurate and precise results. Whether you require qualitative or quantitative analysis, we have the expertise to support your project at every stage.

Detection of Binding Antibodies

We offer a diverse array of assays designed to detect binding antibodies. Our portfolio includes highly effective lateral flow immunoassays, ELISA (Enzyme-Linked Immunosorbent Assay), and Chemiluminescence immunoassays. These assays utilize state-of-the-art techniques to identify and quantify binding antibodies with precision and sensitivity.

Detection of Neutralizing Antibodies

In addition to binding antibody assays, we provide specialized assays for the detection of neutralizing antibodies. Our virus neutralization assays are specifically designed to evaluate the effectiveness of antibodies in inhibiting viral activity. These assays play a crucial role in assessing immune response and vaccine development.

Highly Sensitive Quantification Assays

At Cerba Research we understand the importance of precise quantification in immunological research. That’s why we offer highly sensitive immunoassays such as Elispot and Haemagglutination inhibition which enable accurate measurement and characterization of immune responses. These assays provide valuable insights into immune cell function and aid in evaluating vaccine efficacy, disease progression, and treatment effectiveness

Advanced Assays for Ligand Biding

Our ligand binding assays are designed to accommodate a wide range of ligands across various applications. Whether you are studying small proteins, antibodies, or other biomolecules, our assays provide a robust and flexible platform to meet your specific research or diagnostic need.

Cutting-Edge Platforms

To support the development, validation, and implementation of our immunoassays, we employ the most advanced platforms in the industry. Our expertise extends to ELISA, MSD (Meso Scale Discovery), LLA (Enzyme-Linked Lectin Assay), and Luminex, ensuring optimal performance and reproducibility for every project.

Customized Immunoassay Test Solutions

We understand that each research project is unique, requiring tailored immunoassay test solutions. Our experienced team collaborates closely with you to design and optimize assays specific to your research needs. We offer flexible options to accommodate various sample types.

Quality Assurance and Regulatory Compliance

Delivering reliable and high-quality data is our utmost priority. Cerba Research Diagnostic Laboratory has adopted a high-quality standard in all operations, testing procedures and reporting. The quality management system is based on NEN-EN-ISO 15189, GLP, GCLP, GSLP, and expanded with elements of GCP, to comply with regulatory requirements and facilitate regulatory submissions. Our commitment to quality ensures that your research findings are robust, reliable, and ready for further development.

Contact us today to discuss your specific requirements and explore how our immuno-assay test services can propel your research forward.

Cerba US Expansion Tour VF.00_04_27_19.Still010

Reach out to our experts and see how we can help advance your clinical trial

Contact Us